Study Proposes Use of AI to Diagnose Autism Spectrum Disorder

Diagnosing autism spectrum disorder (ASD) is still a daunting challenge because of the degree of complexity involved, requiring highly specialized professionals. Autism is a multifactorial neurodevelopment disorder with widely varying symptoms. In the United States, about 1 in 36 children have been diagnosed with ASD, according to the Centers for Disease Control and Prevention (CDC), and yet there are no biochemical markers to identify it with precision. A quantitative diagnostic method is proposed by Brazilian researchers in an article published in the journal Scientific Reports.

The study was based on brain imaging data for 500 people, about half of whom (242) had been diagnosed with ASD. Machine learning techniques were applied to the data. "We began developing our methodology by collecting functional magnetic resonance imaging [fMRI] and electroencephalogram [EEG] data," said Francisco Rodrigues, last author of the article. He is a professor at the University of São Paulo's Institute of Mathematics and Computer Science (ICMC-USP) in São Carlos, Brazil, and his contribution to the research was supported by FAPESP.

"We compared maps of people with and without ASD and found that diagnosis was possible using this methodology," Rodrigues said.

The researchers fed a machine learning algorithm with these maps. Based on the learned examples, the system was able to determine which brain alterations were associated with ASD with above 95% accuracy.

Much recent research proposes methods for diagnosing ASD based on machine learning but uses a single statistical parameter, ignoring brain network organization, which is the innovation featured by this study, the article notes. Brain maps or cortical networks show how brain regions are connected. Research on these networks began about 20 years ago and has offered a new vision of neuroscience. "Just as a road with interruptions alters the traffic in a region, a brain with alterations leads to changes in behavior," Rodrigues said.

The analysis of fMRI data highlighted changes in certain brain regions associated with cognitive, emotional, learning and memory processes. The cortical networks of ASD patients displayed more segregation, less distribution of information and less connectivity compared to controls.

"Until a few years ago, little was known about the alterations that lead to the symptoms of ASD. Now, however, brain alterations in ASD patients are known to be associated with certain behaviors, although anatomical research shows that the alterations are hard to see, making diagnosis of mild ASD much harder. Our study is an important step in the development of novel methodologies that can help us obtain a deeper understanding of this neurodivergence," Rodrigues said.

The methodology is under development and will take years to implement. Nevertheless, it will contribute to the understanding of cerebral differences and will be useful in future to assist specialists, especially in cases involving diagnostic uncertainty.

A wide range of applications

For Rodrigues, the study is a small contribution to a deeper understanding of how ASD relates to brain alterations. Much more research is needed for this automatic diagnostic method to be put into practice. Brain mapping can be useful to diagnose other conditions apart from ASD. Previous work shows that brain maps can also be used to detect schizophrenia with considerable accuracy.

"We began developing novel methods to identify mental disorders a decade ago. We found that the diagnosis of schizophrenia can be much improved using brain networks and artificial intelligence. We also recently studied use of the methodology to investigate Alzheimer's disease and found accurate automatic diagnosis to be possible," Rodrigues said, referring to a study reported in 2022 in the Journal of Neural Engineering.

Many challenges have to be surmounted, such as small databases and the difficulty of collecting data, but as a general methodology it can help scientists understand several conditions, and one of the group’s goals is investigating the relationships among mental disorders.

"How similar in terms of brain alterations are schizophrenia and Alzheimer's? If we can find correlations between mental disorders, we may be able to develop novel medications and similar treatments for different conditions, or even adapt treatment for one condition to use in another. We're a long way from this, but the path ahead is promising," Rodrigues said.

The researchers expect a better understanding of how brain alterations influence behavior to lead to more humane and efficient treatment as well as more effective public policies. The complexity of the subject is evident from the interdisciplinary nature of the research involved. The group comprised physicists, statisticians, physicians and neuroscientists from centers in Brazil, France and Germany. They analyzed medical data compiled by neurologists and brain imaging studies by neuroscientists, as well as algorithms developed by physicists and statisticians.

The study was part of the PhD research of Caroline Alves, first author of the article. Her background is in physics, physical and biomolecular sciences, and computer science. FAPESP also supported two other authors of the article via PhD scholarships: Aruane Pineda (grant no. 19/22277-0) and Kirstin Roster (grant no. 19/26595-7), both of whom were supervised by Rodrigues.

Alves CL, Toutain TGLO, de Carvalho Aguiar P, Pineda AM, Roster K, Thielemann C, Porto JAM, Rodrigues FA.
Diagnosis of autism spectrum disorder based on functional brain networks and machine learning.
Sci Rep. 2023 May 18;13(1):8072. doi: 10.1038/s41598-023-34650-6

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...